51
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Dementia in Latin America: Epidemiological Evidence and Implications for Public Policy

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Population aging is among the most important global transformations. Today, 12% of the world population is of age 60 and over and by the middle of this century this segment will represent 21.5%. The increase in population of those aged 80 and over, also referred to as the “oldest old” or the “very elderly”, will be even more pronounced, going from 1.7% of the population to 4.5% within the same period. Compared to European and North American countries, Latin America (LA) is experiencing this unprecedented demographic change at a significantly faster rate. Due to demographic and health transitions, the number of people with dementia will rise from 7.8 million in 2013 to over 27 million by 2050. Nowadays, the global prevalence of dementia in LA has reached 7.1%, with Alzheimer’s Disease (AD) being the most frequent type. This level is similar to those found in developed countries; however, the dementia rate is twice as high as that of the 65–69 years age group in developed countries. In addition, the prevalence and incidence of dementia is higher among illiterate people. Mortality rates due to dementia have risen considerably. The burden and costs of the disease are high and must be covered by patients’ families. The prevention of dementia and the development of long-term care policies and plans for people with dementia in LA, which take into account regional differences and similarities, should be urgent priorities.

          Related collections

          Most cited references63

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis

          Objectives Detection of dementia is essential for improving the lives of patients but the extent of underdetection worldwide and its causes are not known. This study aimed to quantify the prevalence of undetected dementia and to examine its correlates. Methods/setting/participants A systematic search was conducted until October 2016 for studies reporting the proportion of undetected dementia and/or its determinants in either the community or in residential care settings worldwide. Random-effects models calculated the pooled rate of undetected dementia and subgroup analyses were conducted to identify determinants of the variation. Primary and secondary outcome measures The outcome measures of interest were the prevalence and determinants of undetected dementia. Results 23 studies were eligible for inclusion in this review. The pooled rate of undetected dementia was 61.7% (95% CI 55.0% to 68.0%). The rate of underdetection was higher in China and India (vs Europe and North America), in the community setting (vs residential/nursing care), age of <70 years, male gender and diagnosis by general practitioner. However, it was lower in the studies using Mini-Mental State Examination (MMSE) diagnosis criteria. Conclusions The prevalence of undetected dementia is high globally. Wide variations in detecting dementia need to be urgently examined, particularly in populations with low socioeconomic status. Efforts are required to reduce diagnostic inequality and to improve early diagnosis in the community.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            2014 Alzheimer's disease facts and figures.

            (2014)
            This report discusses the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, costs of care, and overall effect on caregivers and society. It also examines the impact of AD on women compared with men. An estimated 5.2 million Americans have AD. Approximately 200,000 people younger than 65 years with AD comprise the younger onset AD population; 5 million are age 65 years or older. By mid-century, fueled in large part by the baby boom generation, the number of people living with AD in the United States is projected to grow by about 9 million. Today, someone in the country develops AD every 67 seconds. By 2050, one new case of AD is expected to develop every 33 seconds, or nearly a million new cases per year, and the total estimated prevalence is expected to be 13.8 million. In 2010, official death certificates recorded 83,494 deaths from AD, making AD the sixth leading cause of death in the United States and the fifth leading cause of death in Americans aged 65 years or older. Between 2000 and 2010, the proportion of deaths resulting from heart disease, stroke, and prostate cancer decreased 16%, 23%, and 8%, respectively, whereas the proportion resulting from AD increased 68%. The actual number of deaths to which AD contributes (or deaths with AD) is likely much larger than the number of deaths from AD recorded on death certificates. In 2014, an estimated 700,000 older Americans will die with AD, and many of them will die from complications caused by AD. In 2013, more than 15 million family members and other unpaid caregivers provided an estimated 17.7 billion hours of care to people with AD and other dementias, a contribution valued at more than $220 billion. Average per-person Medicare payments for services to beneficiaries aged 65 years and older with AD and other dementias are more than two and a half times as great as payments for all beneficiaries without these conditions, and Medicaid payments are 19 times as great. Total payments in 2014 for health care, long-term care, and hospice services for people aged 65 years and older with dementia are expected to be $214 billion. AD takes a stronger toll on women than men. More women than men develop the disease, and women are more likely than men to be informal caregivers for someone with AD or another dementia. As caregiving responsibilities become more time consuming and burdensome or extend for prolonged durations, women assume an even greater share of the caregiving burden. For every man who spends 21 to more than 60 hours per week as a caregiver, there are 2.1 women. For every man who lives with the care recipient and provides around-the-clock care, there are 2.5 women. In addition, for every man who has provided caregiving assistance for more than 5 years, there are 2.3 women.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The worldwide societal costs of dementia: Estimates for 2009.

              The purpose of this study was to update the previous estimate of the worldwide cost of dementia in 2005 to 2009. The cost model is based on prevalence estimates, country and region-specific data on Gross Domestic Product per person and average wage, with results from previously published cost-of-illness studies in different countries. Prevalence figures are updated to 2009 and costs were adjusted to 2009 constant US dollars ($). The total worldwide societal cost of dementia, based on a dementia population of 34.4 million demented persons, was estimated to $422 billion in 2009, including $142 billion for informal care (34%). The worldwide cost of dementia has increased by 34% (18% in fixed prices) between 2005 and 2009. 2010. Published by Elsevier Inc.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Aging Neurosci
                Front Aging Neurosci
                Front. Aging Neurosci.
                Frontiers in Aging Neuroscience
                Frontiers Media S.A.
                1663-4365
                13 July 2017
                2017
                : 9
                : 221
                Affiliations
                [1] 1Unidad de diagnóstico de deterioro cognitivo y prevención de demencia, Departamento de Neurología, Instituto Peruano de Neurociencias Lima, Peru
                [2] 2Gerosciences Center for Brain Health and Metabolism (GERO) Santiago, Chile
                [3] 3Department of Surgery and Cancer, National Institute for Health Research Imperial Patient Safety Translational Research Centre, Imperial College London London, United Kingdom
                [4] 4Psychology Department, Faculty of Social Sciences, Universidad de Chile Santiago, Chile
                [5] 5Physiopathology Department, ICBM, and East Neuroscience Department, Faculty of Medicine, Universidad de Chile Santiago, Chile
                [6] 6Cognitive Neurology and Dementia Unit, Neurology Department, Hospital del Salvador Santiago, Chile
                [7] 7Center for Advanced Research in Education (CIAE), Universidad de Chile Santiago, Chile
                [8] 8Servicio de Neurología, Departamento de Medicina, Clínica Alemana-Universidad del Desarrollo Santiago, Chile
                Author notes

                Edited by: Patricia Cogram, Fraunhofer Research, Chile

                Reviewed by: Paulo Caramelli, Universidade Federal de Minas Gerais, Brazil; Gladys Elena Maestre, University of Texas Rio Grande Valley, United States

                *Correspondence: Nilton Custodio ncustodio@ 123456ipn.pe Andrea Slachevsky andrea.slachevsky@ 123456uchile.cl
                Article
                10.3389/fnagi.2017.00221
                5508025
                28751861
                567fd492-e1e5-498f-a609-12e2115a37b0
                Copyright © 2017 Custodio, Wheelock, Thumala and Slachevsky.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 23 November 2016
                : 23 June 2017
                Page count
                Figures: 1, Tables: 4, Equations: 0, References: 95, Pages: 11, Words: 9726
                Funding
                Funded by: Comisión Nacional de Investigación Cientà­fica y Tecnológica 10.13039/501100002848
                Award ID: CONICYT/ FONDECYT/ 11404223, CONICYT/ FONDAP/15150012, Associative Research Program of CONICYT under Basal Funds Grant for Centers of Excellence FB 0003
                Categories
                Neuroscience
                Review

                Neurosciences
                latin america,dementia,epidemiology,public policy,alzheimer,dementia plan,caregiver burden,cost of dementia

                Comments

                Comment on this article